Peregrine Pharmaceuticals CEO Roger Lias' 2019 pay jumps 25% to $880K
Peregrine Pharmaceuticals reports 2019 executive compensation
By ExecPay News
Published: August 21, 2019
Peregrine Pharmaceuticals reported fiscal year 2019 executive compensation information on August 21, 2019.
In 2019, five executives at Peregrine Pharmaceuticals received on average a compensation package of $559K, a 2% decrease compared to previous year.
Average pay of disclosed executives at Peregrine Pharmaceuticals
Roger J. Lias, Chief Executive Officer, received $880K in total, which increased by 25% compared to 2018. 53% of Lias' compensation, or $463K, was in salary. Lias also received $189K in non-equity incentive plan, $117K in option awards, as well as $111K in other compensation.
For fiscal year 2019, the median employee pay was $96,570 at Peregrine Pharmaceuticals. Therefore, the ratio of Roger J. Lias' pay to the median employee pay was 9 to one.
Daniel R. Hart, Chief Financial Officer, received a compensation package of $788K. 51% of the compensation package, or $401K, was in option awards.
Mark R. Ziebell, General Counsel, earned $485K in 2019, a 18% increase compared to previous year.
Stephen Hedberg, Principal Financial Officer and Principal Accounting Officer, received $382K in 2019.
Paul J. Lytle, Chief Financial Officer, earned $258K in 2019, a 44% decrease compared to previous year.
Peregrine Pharmaceuticals' fiscal year ends on April 30.
Related executives
Roger Lias
Peregrine Pharmaceuticals
Chief Executive Officer
Daniel Hart
Peregrine Pharmaceuticals
Chief Financial Officer
Paul Lytle
Peregrine Pharmaceuticals
Chief Financial Officer
Mark Ziebell
Peregrine Pharmaceuticals
General Counsel
Stephen Hedberg
Peregrine Pharmaceuticals
Principal Financial Officer and Principal Accounting Officer
You may also like
Source: SEC filing on August 21, 2019.